Iterum Therapeutics plc 4/A SEC Filings

Filed On	Filing
05 Jun 2023	Form 4/A: Dunne Michael W., Director Received 1,299 shares by exercise or conversion
27 Feb 2023	Form 4/A: Dunne Michael W., Director Holds 35,575 shares of Ordinary Shares
15 Mar 2022	Form 4/A: Matthews Judith M., Chief Financial Officer Sold 63,340 shares ($19.6K)

Comments